NOW
ENROLLING

Phase III trial in
relapsed/refractory
acute myeloid
leukemia (AML)

Patients with
relapsed/refractory
AML

Learn about this
Phase III AML
trial

MIRROS
Genentech BioOncology

© 2019 Genentech USA, Inc.
All rights reserved. BIO/040218/0052(2)